home All News open_in_new Full Article

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer’s Association International Conference

VANCOUVER, British Columbia & DALLAS — Alpha Cognition Inc. (NASDAQ: ACOG) (the “Company” or “Alpha Cognition”) today announced three upcoming presentations at the 2025 Alzheimer’s Association International Conference (the “AAIC”), taking place July 27–31, 2025 in Toronto, Canada. The presentations will highlight clinical studies supporting ZUNVEYL (benzgalantamine), the Company’s lead product and a novel galantamine […]


today 4 h. ago attach_file Society

attach_file Science
attach_file Society
attach_file Culture
attach_file Politics
attach_file Sport
attach_file Other
attach_file Politics


ID: 207964665
Add Watch Country

arrow_drop_down